Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 284

1.

Two patterns of cerebral metabolite abnormalities are detected on proton magnetic resonance spectroscopy in HIV-infected subjects commencing antiretroviral therapy.

Winston A, Duncombe C, Li PC, Gill JM, Kerr SJ, Puls RL, Taylor-Robinson SD, Emery S, Cooper DA; Altair Study Group.

Neuroradiology. 2012 Dec;54(12):1331-9. doi: 10.1007/s00234-012-1061-5. Epub 2012 Jul 7.

PMID:
22772471
2.

Does choice of combination antiretroviral therapy (cART) alter changes in cerebral function testing after 48 weeks in treatment-naive, HIV-1-infected individuals commencing cART? A randomized, controlled study.

Winston A, Duncombe C, Li PC, Gill JM, Kerr SJ, Puls R, Petoumenos K, Taylor-Robinson SD, Emery S, Cooper DA; Altair Study Group.

Clin Infect Dis. 2010 Mar 15;50(6):920-9. doi: 10.1086/650743. Erratum in: Clin Infect Dis. 2010 Sep 1;51(5):638.

PMID:
20146627
3.

Evaluation of metabolic changes within the normal appearing gray and white matters in neurologically asymptomatic HIV-1-positive and HCV-positive patients: magnetic resonance spectroscopy and immunologic correlation.

Bladowska J, Zimny A, Kołtowska A, Szewczyk P, Knysz B, Gąsiorowski J, Furdal M, Sąsiadek MJ.

Eur J Radiol. 2013 Apr;82(4):686-92. doi: 10.1016/j.ejrad.2012.11.029. Epub 2012 Dec 14.

PMID:
23246331
4.

A multicenter in vivo proton-MRS study of HIV-associated dementia and its relationship to age.

Chang L, Lee PL, Yiannoutsos CT, Ernst T, Marra CM, Richards T, Kolson D, Schifitto G, Jarvik JG, Miller EN, Lenkinski R, Gonzalez G, Navia BA; HIV MRS Consortium.

Neuroimage. 2004 Dec;23(4):1336-47.

PMID:
15589098
5.

Relationships among brain metabolites, cognitive function, and viral loads in antiretroviral-naïve HIV patients.

Chang L, Ernst T, Witt MD, Ames N, Gaiefsky M, Miller E.

Neuroimage. 2002 Nov;17(3):1638-48.

PMID:
12414302
6.

Antiretroviral therapy and its influence on the stage of brain damage in patients with HIV - 1H MRS evaluation.

Tarasów E, Wiercińska-Drapało A, Jaroszewicz J, Orzechowska-Bobkiewicz A, Dzienis W, Prokopowicz D, Walecki J.

Med Sci Monit. 2004 Jun;10 Suppl 3:101-6.

7.

Highly active antiretroviral therapy reverses brain metabolite abnormalities in mild HIV dementia.

Chang L, Ernst T, Leonido-Yee M, Witt M, Speck O, Walot I, Miller EN.

Neurology. 1999 Sep 11;53(4):782-9.

PMID:
10489041
8.

Altered neurometabolite development in HIV-infected children: correlation with neuropsychological tests.

Keller MA, Venkatraman TN, Thomas A, Deveikis A, LoPresti C, Hayes J, Berman N, Walot I, Padilla S, Johnston-Jones J, Ernst T, Chang L.

Neurology. 2004 May 25;62(10):1810-7.

PMID:
15159483
9.

A multi-center 1H MRS study of the AIDS dementia complex: validation and preliminary analysis.

Lee PL, Yiannoutsos CT, Ernst T, Chang L, Marra CM, Jarvik JG, Richards TL, Kwok EW, Kolson DL, Simpson D, Tang CY, Schifitto G, Ketonen LM, Meyerhoff DJ, Lenkinski RE, Gonzalez RG, Navia BA; HIV MRS Consortium.

J Magn Reson Imaging. 2003 Jun;17(6):625-33.

PMID:
12766890
10.

Detection of human immunodeficiency virus induced inflammation and oxidative stress in lenticular nuclei with magnetic resonance spectroscopy despite antiretroviral therapy.

Roc AC, Ances BM, Chawla S, Korczykowski M, Wolf RL, Kolson DL, Detre JA, Poptani H.

Arch Neurol. 2007 Sep;64(9):1249-57. Epub 2007 Jul 9.

PMID:
17620480
11.
12.

Quantitative multivoxel proton MR spectroscopy study of brain metabolites in patients with amnestic mild cognitive impairment: a pilot study.

Yang ZX, Huo SS, Cheng XF, Xu ZF, Cao Z, Zeng JX, Xiao YY, You KZ, Chen W, Liu YY, Wu RH.

Neuroradiology. 2012 May;54(5):451-8. doi: 10.1007/s00234-011-0900-0. Epub 2011 Jul 8.

PMID:
21739221
13.

Progressive cerebral injury in the setting of chronic HIV infection and antiretroviral therapy.

Gongvatana A, Harezlak J, Buchthal S, Daar E, Schifitto G, Campbell T, Taylor M, Singer E, Algers J, Zhong J, Brown M, McMahon D, So YT, Mi D, Heaton R, Robertson K, Yiannoutsos C, Cohen RA, Navia B; HIV Neuroimaging Consortium.

J Neurovirol. 2013 Jun;19(3):209-18. doi: 10.1007/s13365-013-0162-1. Epub 2013 Apr 24.

14.

Two-dimensional 1H MR spectroscopy of the brain in human immunodeficiency virus (HIV)-infected children.

Banakar S, Thomas MA, Deveikis A, Watzl JQ, Hayes J, Keller MA.

J Magn Reson Imaging. 2008 Apr;27(4):710-7. doi: 10.1002/jmri.21251.

PMID:
18383256
15.

Localised 1H-MR spectroscopy for metabolic characterisation of diffuse and focal brain lesions in patients infected with HIV.

Simone IL, Federico F, Tortorella C, Andreula CF, Zimatore GB, Giannini P, Angarano G, Lucivero V, Picciola P, Carrara D, Bellacosa A, Livrea P.

J Neurol Neurosurg Psychiatry. 1998 Apr;64(4):516-23.

16.

Neurometabolite Alterations Associated With Cognitive Performance in Perinatally HIV-Infected Children.

Van Dalen YW, Blokhuis C, Cohen S, Ter Stege JA, Teunissen CE, Kuhle J, Kootstra NA, Scherpbier HJ, Kuijpers TW, Reiss P, Majoie CB, Caan MW, Pajkrt D.

Medicine (Baltimore). 2016 Mar;95(12):e3093. doi: 10.1097/MD.0000000000003093.

17.

Evaluation of early cerebral metabolic, perfusion and microstructural changes in HCV-positive patients: a pilot study.

Bladowska J, Zimny A, Knysz B, Małyszczak K, Kołtowska A, Szewczyk P, Gąsiorowski J, Furdal M, Sąsiadek MJ.

J Hepatol. 2013 Oct;59(4):651-7. doi: 10.1016/j.jhep.2013.05.008. Epub 2013 May 13.

PMID:
23680314
18.

Effects of human immunodeficiency virus and methamphetamine on cerebral metabolites measured with magnetic resonance spectroscopy.

Taylor MJ, Schweinsburg BC, Alhassoon OM, Gongvatana A, Brown GG, Young-Casey C, Letendre SL, Grant I; HNRC Group.

J Neurovirol. 2007 Apr;13(2):150-9.

PMID:
17505983
19.

Predictors of CNS injury as measured by proton magnetic resonance spectroscopy in the setting of chronic HIV infection and CART.

Harezlak J, Cohen R, Gongvatana A, Taylor M, Buchthal S, Schifitto G, Zhong J, Daar ES, Alger JR, Brown M, Singer EJ, Campbell TB, McMahon D, So YT, Yiannoutsos CT, Navia BA; HIV Neuroimaging Consortium.

J Neurovirol. 2014 Jun;20(3):294-303. doi: 10.1007/s13365-014-0246-6. Epub 2014 Apr 3.

20.

Basal ganglia metabolite abnormalities in minor motor disorders associated with human immunodeficiency virus type 1.

von Giesen HJ, Wittsack HJ, Wenserski F, Köller H, Hefter H, Arendt G.

Arch Neurol. 2001 Aug;58(8):1281-6.

PMID:
11493169

Supplemental Content

Support Center